United Orthopedic (ROCO:4129) Cyclically Adjusted Revenue per Share: NT$41.41 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4129 United Orthopedic Corp ROCO:4129
75 GF Score
Price NT$85.20
GF Value NT$128.93
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is United Orthopedic Cyclically Adjusted Revenue per Share?

United Orthopedic ROCO:4129 -2.85% 75 Cyclically Adjusted Revenue per Share is NT$41.41 as of Mar. 2026. GuruFocus rates ROCO:4129 with a GF Score™ of 75/100 and a GF Value™ of NT$128.93 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

United Orthopedic's adjusted revenue per share for the three months ended in Mar. 2026 was NT$15.148. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$41.41 for the trailing ten years ended in Mar. 2026.

During the past 12 months, United Orthopedic's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of United Orthopedic was 11.90% per year. The lowest was 10.00% per year. And the median was 10.50% per year.

As of today (2026-08-15), United Orthopedic's current stock price is NT$85.20. United Orthopedic's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was NT$41.41. United Orthopedic's Cyclically Adjusted PS Ratio of today is 2.06.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of United Orthopedic was 3.31. The lowest was 0.96. And the median was 1.92.


United Orthopedic  (ROCO:4129) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

United Orthopedic's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=85.20/41.41
=2.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of United Orthopedic was 3.31. The lowest was 0.96. And the median was 1.92.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


United Orthopedic Cyclically Adjusted Revenue per Share Related Terms


United Orthopedic Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for United Orthopedic's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

United Orthopedic Cyclically Adjusted Revenue per Share Chart

United Orthopedic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.80 29.90 32.95 36.22 39.81

United Orthopedic Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.35 38.18 39.17 39.81 41.41

ROCO:4129 vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, United Orthopedic's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Orthopedic Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, United Orthopedic's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where United Orthopedic's Cyclically Adjusted PS Ratio falls into.


ROCO:4129
75GF Score
United Orthopedic Corp ROCO:4129
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

United Orthopedic Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, United Orthopedic's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=15.148/330.2130*330.2130
=15.148

Current CPI (Mar. 2026) = 330.2130.

United Orthopedic Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 4.940 241.018 6.768
201609 4.302 241.428 5.884
201612 5.270 241.432 7.208
201703 5.075 243.801 6.874
201706 7.594 244.955 10.237
201709 7.127 246.819 9.535
201712 6.447 246.524 8.636
201803 6.778 249.554 8.969
201806 7.691 251.989 10.078
201809 6.438 252.439 8.421
201812 7.013 251.233 9.218
201903 6.627 254.202 8.609
201906 7.805 256.143 10.062
201909 7.408 256.759 9.527
201912 6.706 256.974 8.617
202003 6.566 258.115 8.400
202006 6.257 257.797 8.015
202009 6.647 260.280 8.433
202012 7.713 260.474 9.778
202103 8.064 264.877 10.053
202106 8.742 271.696 10.625
202109 7.893 274.310 9.502
202112 9.221 278.802 10.921
202203 7.562 287.504 8.685
202206 7.844 296.311 8.741
202209 7.987 296.808 8.886
202212 11.846 296.797 13.180
202303 10.777 301.836 11.790
202306 10.417 305.109 11.274
202309 9.868 307.789 10.587
202312 11.749 306.746 12.648
202403 11.126 312.332 11.763
202406 11.824 314.175 12.428
202409 11.682 315.301 12.234
202412 13.657 315.605 14.289
202503 13.458 319.799 13.896
202506 13.921 322.561 14.251
202509 14.675 324.800 14.920
202512 14.705 324.054 14.984
202603 15.148 330.213 15.148

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$41.41 mean?
United Orthopedic (ROCO:4129) has a Cyclically Adjusted Revenue per Share of NT$41.41 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on United Orthopedic and its competitors.
Is United Orthopedic's Cyclically Adjusted Revenue per Share too high?
United Orthopedic's current Cyclically Adjusted Revenue per Share is NT$41.41. Overall, United Orthopedic has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does United Orthopedic's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
United Orthopedic's Cyclically Adjusted Revenue per Share of NT$41.41 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on United Orthopedic and its competitors. United Orthopedic's current Cyclically Adjusted Revenue per Share is NT$41.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Orthopedic stock overvalued right now?
Based on GuruFocus' analysis, United Orthopedic (ROCO:4129) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$128.93, compared to a current price of NT$85.20 — trading 33.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$41.41. United Orthopedic's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For United Orthopedic (ROCO:4129), the current Cyclically Adjusted Revenue per Share is NT$41.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is United Orthopedic (ROCO:4129) Overvalued in 2026?

Based on GuruFocus' analysis, United Orthopedic stock appears to be undervalued. The current stock price of NT$85.20 is trading 33.9% below its estimated GF Value™ of NT$128.93. GuruFocus considers United Orthopedic to be Significantly Undervalued.

Key valuation signals for ROCO:4129:

  • Cyclically Adjusted Revenue per Share: NT$41.41
  • GF Value™: NT$128.93 vs. price of NT$85.20 (33.9% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the ROCO:4129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


United Orthopedic Business Description

Address 12th Floor, No.80, Section 1, Chenggong Road, Yonghe District, New Taipei City, TWN, 234634
United Orthopedic Corp is engaged in the research, development, production, manufacturing, and sales of orthopedic implants, orthopedic surgical instruments and manufacturing equipment, special metal and plastics materials, as well as the import and export of the aforementioned products. Its products include Hip System, Knee System, and Limb Salvage.
75GF Score

Get the complete analysis for ROCO:4129

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$85.20
Price
NT$128.93
GF Value